Literature DB >> 19427206

The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives.

Matthew J Walters1, Anna L Blobaum, Philip J Kingsley, Andrew S Felts, Gary A Sulikowski, Lawrence J Marnett.   

Abstract

Sulindac sulfide is a benzylidene-indene that is a potent, time-dependent inhibitor of cyclooxygenases-1 and -2. Removal of the 2'-methyl group from the indene ring dramatically reduces time-dependent inhibition of both enzymes but also changes the geometry of the benzylidene double bond from Z to E. Herein, we explore the importance of double bond geometry on cyclooxygenase inhibition. The Z-isomer of 2'-des-methyl sulindac sulfide was synthesized by reduction of a bromoindene precursor or by photoisomerization of the E-isomer. The Z-isomer inhibited both cyclooxygenases, but with diminished potency compared to sulindac sulfide. Thus, although the 2'-methyl group is a major determinant of time-dependent cyclooxygenase inhibition, the geometry of the benzylidene double bond plays a role as well.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427206      PMCID: PMC2760071          DOI: 10.1016/j.bmcl.2009.04.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Cyclooxygenase enzymes: catalysis and inhibition.

Authors:  R G Kurumbail; J R Kiefer; L J Marnett
Journal:  Curr Opin Struct Biol       Date:  2001-12       Impact factor: 6.809

2.  Stimulation and blockade of prostaglandin biosynthesis.

Authors:  W L Smith; W E Lands
Journal:  J Biol Chem       Date:  1971-11       Impact factor: 5.157

3.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

Review 4.  Mechanism of action of anti-inflammatory drugs.

Authors:  J R Vane; R M Botting
Journal:  Scand J Rheumatol Suppl       Date:  1996

5.  Molecular basis of the time-dependent inhibition of cyclooxygenases by indomethacin.

Authors:  Jeffery J Prusakiewicz; Andrew S Felts; Bonnie S Mackenzie; Lawrence J Marnett
Journal:  Biochemistry       Date:  2004-12-14       Impact factor: 3.162

6.  Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides.

Authors:  Christine A Harman; Melissa V Turman; Kevin R Kozak; Lawrence J Marnett; William L Smith; R Michael Garavito
Journal:  J Biol Chem       Date:  2007-07-26       Impact factor: 5.157

7.  Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.

Authors:  L H Rome; W E Lands
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

8.  Desmethyl derivatives of indomethacin and sulindac as probes for cyclooxygenase-dependent biology.

Authors:  Andrew S Felts; Chuan Ji; Jennifer B Stafford; Brenda C Crews; Philip J Kingsley; Carol A Rouzer; Mary Kay Washington; Kotha Subbaramaiah; Brianna S Siegel; Shiu M Young; Andrew J Dannenberg; Lawrence J Marnett
Journal:  ACS Chem Biol       Date:  2007-06-29       Impact factor: 5.100

9.  Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition.

Authors:  Andrew S Felts; Brianna S Siegel; Shiu M Young; Christopher W Moth; Terry P Lybrand; Andrew J Dannenberg; Lawrence J Marnett; Kotha Subbaramaiah
Journal:  J Med Chem       Date:  2008-07-30       Impact factor: 7.446

  9 in total
  5 in total

1.  The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.

Authors:  Xingya Wang; Philip J Kingsley; Larry J Marnett; Thomas E Eling
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

2.  High-throughput quantification of bioactive lipids by MALDI mass spectrometry: application to prostaglandins.

Authors:  Joseph D Manna; Michelle L Reyzer; Joey C Latham; C David Weaver; Lawrence J Marnett; Richard M Caprioli
Journal:  Anal Chem       Date:  2011-08-01       Impact factor: 6.986

3.  Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.

Authors:  Andy J Liedtke; Brenda C Crews; Cristina M Daniel; Anna L Blobaum; Philip J Kingsley; Kebreab Ghebreselasie; Lawrence J Marnett
Journal:  J Med Chem       Date:  2012-02-14       Impact factor: 7.446

4.  Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition.

Authors:  Md Mominur Rahman; Md Junaid; S M Zahid Hosen; Mohammad Mostafa; Lei Liu; Kirsten Benkendorff
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

5.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.